Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting
- Ludwig, H.
- Ramasamy, K.
- Mateos, M.-V.
- Kishore, B.
- Gergely, V.
- Ladicka, M.
- Ori, A.
- Simoni, L.
- Bent-Ennakhil, N.
- Stull, D.M.
- Gavini, F.
- Terpos, E.
- Hájek, R.
ISSN: 2152-2669, 2152-2650
Année de publication: 2024
Volumen: 24
Número: 2
Pages: e40-e49.e3
Type: Article